137 research outputs found

    Come On In, The Writing\u27s Fine: Preserving Voice and Generating Enthusiasm in My English 100 Syllabus

    Get PDF
    This thesis explores the potential for creating a composition syllabus that presents a model of good writing, is an enthusiastic invitation to the discipline, and provides a clear roadmap to success, not only for the course, but also for the studentsā€™ college career. This is especially useful for an increasingly diverse student community that arrives to college with a varying knowledge of the academic institution, with its specialized language and systems. The project explores the existing research on syllabus crafting, uses current composition studies and a survey of English 100 students to interrogate the rhetorical situation of the authorā€™s own syllabus, and finally reflects upon a section-bysection revision of that syllabus. With a present and positive voice from the teacher that includes students in the process of their own learning, a dynamic composition syllabus can initiate trusting relationships in the classroom, and support greater success for the students

    The REVERE project:Experiments with the application of probabilistic NLP to systems engineering

    Get PDF
    Despite natural languageā€™s well-documented shortcomings as a medium for precise technical description, its use in software-intensive systems engineering remains inescapable. This poses many problems for engineers who must derive problem understanding and synthesise precise solution descriptions from free text. This is true both for the largely unstructured textual descriptions from which system requirements are derived, and for more formal documents, such as standards, which impose requirements on system development processes. This paper describes experiments that we have carried out in the REVERE1 project to investigate the use of probabilistic natural language processing techniques to provide systems engineering support

    Adaptation tipping points of awetland under a drying climate

    Get PDF
    Wetlands experience considerable alteration to their hydrology, which typically contributes to a decline in their overall ecological integrity. Wetland management strategies aim to repair wetland hydrology and attenuate wetland loss that is associated with climate change. However, decision makers often lack the data needed to support complex social environmental systems models, making it difficult to assess the effectiveness of current or past practices. Adaptation Tipping Points (ATPs) is a policy-oriented method that can be useful in these situations. Here, a modified ATP framework is presented to assess the suitability of ecosystem management when rigorous ecological data are lacking. We define the effectiveness of the wetland management strategy by its ability to maintain sustainable minimum water levels that are required to support ecological processes. These minimum water requirements are defined in water management and environmental policy of the wetland. Here, we trial the method on Forrestdale Lake, a wetland in a region experiencing a markedly drying climate. ATPs were defined by linking key ecological objectives identified by policy documents to threshold values for water depth. We then used long-term hydrologic data (1978ā€“2012) to assess if and when thresholds were breached. We found that from the mid-1990s, declining wetland water depth breached ATPs for the majority of the wetland objectives. We conclude that the wetland management strategy has been ineffective from the mid-1990s, when the regionā€™s climate dried markedly. The extent of legislation, policies, and management authorities across different scales and levels of governance need to be understood to adapt ecosystem management strategies. Empirical verification of the ATP assessment is required to validate the suitability of the method. However, in general we consider ATPs to be a useful desktop method to assess the suitability of management when rigorous ecological data are lacking

    Patient Transport in the Time of COVID-19: Using Health Care Failure Mode and Effect Analysis with Simulation to Test and Modify a Protocol

    Get PDF
    Introduction: In March 2020, in response to the COVID-19 pandemic, an interprofessional, interdisciplinary team at Maine Medical Center used Healthcare Failure Mode and Effect Analysis (HFMEA) and in situ simulation to rapidly identify and mitigate latent safety threats (LST) in patient transport protocols. Methods: Following HFMEA steps, stakeholders representing a variety of disciplines assembled to address transport of patients with COVID-19. A process map was created to describe the process. With hazard analysis using table-top simulation followed by in situ simulation, we identified, categorized, and scored LSTs. Mitigation strategies were identified during structured debriefing. Results: Fourteen LSTs were identified in the categories of infection prevention (4), care coordination (2), equipment (2), facilities (2), teams (2), clinical skills (1), and diagnosis and treatment (1). Of these, 10 had ā€œcriticalā€ hazard scores. Mitigation solutions were tested with in situ simulation. Results were shared with leadership and led to changes in hospital-wide protocols. Discussion: The COVID-19 pandemic presented an urgent need to create or adapt protocols to keep patients and staff safe. Our team combined simulation with HFMEA methodology to improve the safety of protocols for transporting patients with COVID-19. Simulation enabled recreation of real-world experience that exposed LSTs more thoroughly than mental walkthroughs alone. Use of HFMEA methodology supported quantifying identified LSTs and proposing mitigation strategies, while in situ simulation facilitated testing many proposed strategies. Conclusions: HFMEA used with in situ simulation provides an effective method to efficiently and thoroughly probe a process for failure modes, providing practical mitigation strategies

    Equipping Health Professions Educators to Better Address Medical Misinformation

    Get PDF
    As part of a cooperative agreement with the US Centers for Disease Control and Prevention (Federal Award Identification Number [FAIN]: NU50CK000586), the Association of American Medical Colleges (AAMC) began a strategic initiative in 2022 both to increase confidence in COVID-19 vaccines and to address medical misinformation and mistrust through education in health professions contexts. Specifically, the AAMC solicited proposals for integrating competency-based, interprofessional strategies to mitigate health misinformation into new or existing curricula. Five Health Professions Education Curricular Innovations subgrantees received support from the AAMC in 2022 and reflected on the implementation of their ideas in a series of meetings over several months. Subgrantees included the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Florida International University Herbert Wertheim College of Medicine, the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, the Maine Medical Center/Tufts University School of Medicine, and the University of Chicago Pritzker School of Medicine. This paper comprises insights from each of the teams and overarching observations regarding the challenges and opportunities involved with leveraging health professions education to address medical misinformation and improve patient health

    Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

    Get PDF

    Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

    Get PDF
    Study question What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? Summary answer International evidence-based guidelines address prioritized questions and outcomes and include 254 recommendations and practice points, to promote consistent, evidence-based care and improve the experience and health outcomes in PCOS. What is known already The 2018 International PCOS Guideline was independently evaluated as high quality and integrated multidisciplinary and consumer perspectives from 6 continents; it is now used in 196 countries and is widely cited. It was based on best available, but generally very low- to low-quality, evidence. It applied robust methodological processes and addressed shared priorities. The guideline transitioned from consensus-based to evidence-based diagnostic criteria and enhanced accuracy of diagnosis, whilst promoting consistency of care. However, diagnosis is still delayed, the needs of those with PCOS are not being adequately met, the evidence quality was low, and evidence-practice gaps persist. Study design, size, and duration The 2023 International Evidence-based Guideline update re-engaged the 2018 network across professional societies and consumer organizations with multidisciplinary experts and women with PCOS directly involved at all stages. Extensive evidence synthesis was completed. Appraisal of Guidelines for Research and Evaluation II (AGREEII)-compliant processes were followed. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was applied across evidence quality, feasibility, acceptability, cost, implementation, and ultimately recommendation strength, and diversity and inclusion were considered throughout. Participants/materials, setting, and methods This summary should be read in conjunction with the full guideline for detailed participants and methods. Governance included a 6-continent international advisory and management committee, 5 guideline development groups, and paediatric, consumer, and translation committees. Extensive consumer engagement and guideline experts informed the update scope and priorities. Engaged international society-nominated panels included paediatrics, endocrinology, gynaecology, primary care, reproductive endocrinology, obstetrics, psychiatry, psychology, dietetics, exercise physiology, obesity care, public health, and other experts, alongside consumers, project management, evidence synthesis, statisticians, and translation experts. Thirty-nine professional and consumer organizations covering 71 countries engaged in the process. Twenty meetings and 5 face-to-face forums over 12 months addressed 58 prioritized clinical questions involving 52 systematic and 3 narrative reviews. Evidence-based recommendations were developed and approved via consensus across 5 guideline panels, modified based on international feedback and peer review, independently reviewed for methodological rigour, and approved by the Australian Government National Health and Medical Research Council. Main results and the role of chance The evidence in the assessment and management of PCOS has generally improved in the past 5 years but remains of low to moderate quality. The technical evidence report and analyses (āˆ¼6000 pages) underpin 77 evidence-based and 54 consensus recommendations, with 123 practice points. Key updates include the following: (1) further refinement of individual diagnostic criteria, a simplified diagnostic algorithm, and inclusion of anti-MĆ¼llerian hormone levels as an alternative to ultrasound in adults only; (2) strengthening recognition of broader features of PCOS including metabolic risk factors, cardiovascular disease, sleep apnoea, very high prevalence of psychological features, and high risk status for adverse outcomes during pregnancy; (3) emphasizing the poorly recognized, diverse burden of disease and the need for greater healthcare professional education, evidence-based patient information, improved models of care, and shared decision-making to improve patient experience, alongside greater research; (4) maintained emphasis on healthy lifestyle, emotional well-being, and quality of life, with awareness and consideration of weight stigma; and (5) emphasizing evidence-based medical therapy and cheaper and safer fertility management. Limitations and reasons for caution Overall, recommendations are strengthened and evidence is improved but remains generally low to moderate quality. Significantly greater research is now needed in this neglected, yet common condition. Regional health system variation was considered and acknowledged, with a further process for guideline and translation resource adaptation provided. Wider implications of the findings The 2023 International Guideline for the Assessment and Management of PCOS provides clinicians and patients with clear advice on best practice, based on the best available evidence, expert multidisciplinary input, and consumer preferences. Research recommendations have been generated, and a comprehensive multifaceted dissemination and translation programme supports the guideline with an integrated evaluation programme
    • ā€¦
    corecore